navigating gene therapy commercialization and reimbursement hurdles in europe
Published 2 years ago • 155 plays • Length 31:56Download video MP4
Download video MP3
Similar videos
-
53:44
plenary session: current trends and challenges surrounding gene therapy commercialization
-
1:01:06
plenary session: how can we successfully commercialize atmps in europe?
-
1:02:00
panel: gene therapy: commercializing a therapeutic product
-
55:45
panel: gene therapy commercialization
-
1:09:59
welcome remarks & plenary session: lessons from pioneers of cell & gene therapy commercialization
-
58:39
panel: navigating regenerative medicine technology assessment and reimbursement
-
1:06:56
panel: innovation shortening the path to commercialization in advanced therapies
-
59:49
plenary session: gene therapy & gene-modified cell therapies
-
1:11:29
panel: acceptance and uptake of cell and gene therapies: lessons learned and future focus
-
44:20
panel: gene therapy: commercialization readiness and market access challenges
-
1:16:01
panel discussion on gene therapy policy in europe
-
13:40
axovant gene therapies
-
14:48
overview of the alliance for regenerative medicine’s initiatives
-
55:01
panel: trends and challenges in gene therapy in europe
-
42:53
panel: strategies for managing access & reimbursement challenges
-
1:09:10
welcome remarks and plenary session: the cell and gene therapy sector's commercial trailblazers
-
59:51
panel: next generation cell and gene therapy in oncology
-
13:37
novartis gene therapies